Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study ; volume:12 ; number:3 ; day:9 ; month:2 ; year:2021 ; pages:801-811 ; date:3.2021
Diabetes therapy ; 12, Heft 3 (9.2.2021), 801-811, 3.2021
- Urheber
-
Williams, David M.
Ruslan, Aliya M.
Khan, Rahim
Vijayasingam, Daneeshanan
Iqbal, Fizzah
Shaikh, Ayesha
Lim, Jia
Chudleigh, Richard
Peter, Rajesh
Udiawar, Maneesh
Bain, Stephen C.
Stephens, Jeffrey W.
Min, Thinzar
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-021-01015-z
- URN
-
urn:nbn:de:101:1-2021040119170212696087
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Williams, David M.
- Ruslan, Aliya M.
- Khan, Rahim
- Vijayasingam, Daneeshanan
- Iqbal, Fizzah
- Shaikh, Ayesha
- Lim, Jia
- Chudleigh, Richard
- Peter, Rajesh
- Udiawar, Maneesh
- Bain, Stephen C.
- Stephens, Jeffrey W.
- Min, Thinzar
- SpringerLink (Online service)
Ähnliche Objekte (12)
Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study
Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study
Semaglutide
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study
Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study
Real-World Use of Oral and Subcutaneous Semaglutide in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study
Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study
Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)
PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice
Real-world use of once-weekly semaglutide in type 2 diabetes: results from SURE Germany
Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population
Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study
Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study
Semaglutide
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study
Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study
Real-World Use of Oral and Subcutaneous Semaglutide in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study
Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study
Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)
PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice
Real-world use of once-weekly semaglutide in type 2 diabetes: results from SURE Germany
Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population
Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study
Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study
Semaglutide
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study
Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study
Real-World Use of Oral and Subcutaneous Semaglutide in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study
Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study
Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)
PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice
Real-world use of once-weekly semaglutide in type 2 diabetes: results from SURE Germany